LADENBURG THALMANN FINANCIAL SERVICES INC. - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q2 2018$1,0000.0%3300.0%0.00%
Q1 2018$1,0000.0%3300.0%0.00%
Q4 2017$1,000
-66.7%
3300.0%0.00%
Q3 2017$3,0000.0%3300.0%0.00%
Q2 2017$3,000
+50.0%
3300.0%0.00%
Q1 2017$2,0003300.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$3,532,0000.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 140,720$2,485,0000.10%
SECTORAL ASSET MANAGEMENT INC 95,000$1,678,0000.07%
Spark Investment Management LLC 18,900$329,0000.05%
Alyeska Investment Group, L.P. 46,833$827,0000.02%
FRANKLIN RESOURCES INC 802,000$14,163,0000.01%
Focused Wealth Management, Inc 450$8,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 740,241$13,073,0000.00%
FMR LLC 900,000$15,894,0000.00%
BlackRock Fund Advisors 149,938$2,648,0000.00%
View complete list of IMMUNE DESIGN CORP shareholders